April 7, 2023
Researchers Leverage Cell Self-Destruction to Treat Brain Tumors
Dominique Higgins, MD, PhD, led research into how a specialized diet can induce a new type of programmed cell death to help kill brain tumor cells.
April 7, 2023
Dominique Higgins, MD, PhD, led research into how a specialized diet can induce a new type of programmed cell death to help kill brain tumor cells.
March 10, 2023
Gregory Scherrer, PharmD, PhD, associate professor of cell biology and physiology and member of the UNC Neuroscience Center, received a Director’s Award for Excellence in Research, and Sarah Linnstaedt, PhD, associate professor of anesthesiology, earned an honorable mention for the Director’s Trailblazer award.
February 15, 2023
Researchers from the UNC School of Medicine, led by Ian Shih, PhD, Professor and Vice Chair of Neurology and Associate Director of the Biomedical Research Imaging Center, revealed the role of the insular cortex in controlling the Default Mode Brain Network.
January 26, 2023
Led by Pew-Thian Yap, PhD, researchers at the UNC School of Medicine created monthly infant brain atlases to help researchers analyze the developing brain to investigate neurological disorders and other conditions.
November 2, 2022
Researchers at the UNC School of Medicine led by Justin Wolter, PhD, and colleagues at the UNC Eshelman School of Pharmacy and Queen Mary University of London, teamed up to publish a comprehensive analysis of what goes awry in brain cells lacking the sacsin protein.
August 8, 2022
UNC School of Medicine researchers, led by Ian Shih, PhD, associate professor of Neurology and Biomedical Research Imaging Center, developed an improved fiber-based optical method to measure activity changes in the brain.
July 21, 2022
Chad Pecot, MD, associate professor of medicine and member of the UNC Lineberger Comprehensive Cancer Center, will lead the new center dedicated to the investigation of the many roles of RNA in health and disease.
May 11, 2022
Read the latest news from the UNC Department of Neurology.
May 10, 2022
James F. Howard, MD, Distinguished Professor of Neuromuscular Disease, Professor of Neurology, Medicine and Allied Health in the UNC School of Medicine, was lead investigator in the Phase 3 clinical trial of zilucoplan.
April 29, 2022
James F. Howard, Jr, MD, in the UNC Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.
April 29, 2022
UNC School of Medicine researchers led by Ian Shih, PhD, used fMRI and a genetic mouse model to study the effects of a neurotransmitter on brain network functional connectivity, a dynamic process crucial for human health and behavior.
April 6, 2022
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.